N-Nitroso Edoxaban Impurity 4
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs .N-Nitroso Edoxaban Impurity 4 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 4 chemically represented as 2-bromo-5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridine . Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 4 .We supply N-Nitroso Edoxaban Impurity 4 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E5043 |
| CAS No | 500572-10-1 |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5044 |
| CAS No | 1255529-25-9 |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5045 |
| CAS No | 1255529-27-1 |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5046 |
| CAS No | 834919-19-6 |
| Mol.F. | C22H25ClN6O5S |
| Mol.Wt. | 521g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5047 |
| CAS No | 767625-11-6 |
| Mol.F. | C19H27N5O5S |
| Mol.Wt. | 437.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5048 |
| CAS No | 740794-83-6 |
| Mol.F. | C23H28ClN7O4S |
| Mol.Wt. | 534g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5049 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E5050 |
| CAS No | 1093351-29-1 |
| Mol.F. | C24H29ClN6O5S |
| Mol.Wt. | 549g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39201 |
| CAS No | 552850-73-4 |
| Mol.F. | C7H5ClN2O3 |
| Mol.Wt. | 200.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39202 |
| CAS No | 365996-12-9 |
| Mol.F. | C9H12N2O2S |
| Mol.Wt. | 212.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39203 |
| CAS No | 1190987-12-2 |
| Mol.F. | C7H8N2O2S : HCl |
| Mol.Wt. | 184.2 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39204 |
| CAS No | 480452-37-7 |
| Mol.F. | C16H22ClN5O3 |
| Mol.Wt. | 367.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39205 |
| CAS No | 1210348-17-6 |
| Mol.F. | C14H24N4O4 |
| Mol.Wt. | 312.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39206 |
| CAS No | 365998-36-3 |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39207 |
| CAS No | 480450-69-9 |
| Mol.F. | C14H25N5O3 |
| Mol.Wt. | 311.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39208 |
| CAS No | 2089454-69-1 |
| Mol.F. | C14H27N3O3 : C2H2O4 |
| Mol.Wt. | 285.4 : 90.0g/mole |
| INV STATUS | CUSTOM SYNTHESIS |